Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “MASTITIS”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 847 records · Page 47Linked to original sources

Electrical conductivity of milk: measurement, modifiers, and meta analysis of mastitis detection performance.

The physics, physiology, and pathology of electrical conductivity of milk are described. Based on a meta analysis, the use of electrical conductivity as a mastitis detection tool is discussed. Most reports were based on subclinical mastitis data. The gold standards of the different reports are discussed. With an overall sensitivity of 66% and an overall specificity of 94%, the predictive value of a positive electrical conductivity test remains low in a low prevalence population. The use of on-line systems for clinical mastitis detection is discussed. On-line systems that combine multiple data and perform multifactorial analyses will be of interest to the dairy industry.

Animals↗

Effect of clinical and subclinical mastitis on lipid composition of teat canal keratin.

Two experiments were conducted to investigate lipid composition of teat canal keratin when different conditions of bacterial colonization and quarter inflammation were present. In Experiment 1, 11 multiparous cows with subclinical mastitis (bacteria present but no visible inflammation) in at least one quarter were selected for study. Quarters that were sampled and found negative for bacterial growth were classified as control. In Experiment 2, 10 multiparous cows with clinical mastitis in one or more quarters were selected. Milk samples from inflamed quarters were cultured to identify mastitis pathogens; these quarters were classified as clinical; all other quarters were classified as control. Teat canal keratin was collected from all quarters just before an a.m. milking, samples were weighed, and lipid determinations were conducted by TLC. Keratin from subclinical quarters compared with keratin from control quarters did not differ in either neutral lipid or fatty acid composition. Total lipid was significantly higher in keratin from teats of clinical quarters than in keratin from control quarters (27.8 vs. 21.5 microgram/mg). Neutral lipid composition of keratin was similar between teats from clinical quarters and teats from control quarters. In Experiment 2, quarter foremilk samples were also obtained to determine lipid composition. The FFA in milk from clinical quarters contained fewer short-chain fatty acids, whereas polyunsaturated fatty acids were significantly higher in milk from clinical quarters.

Animals↗

Kinetics and characteristics of bovine neutrophil alkaline phosphatase during acute Escherichia coli mastitis.

Alkaline phosphatase activity of isolated bovine blood neutrophils was investigated before and during experimentally induced Escherichia coli mastitis. Activities markedly increased 1 wk after infection in neutrophils of cows suffering from moderate or from severe disease. Elevated neutrophil alkaline phosphatase activity did not correlate with a specific stage of maturating postmitotic neutrophils appearing in circulation during mastitis. Neutrophil alkaline phosphatase from healthy cows before infection and from mastitic cows was characterized by means of thermostability, specific inhibitor patterns, slab gel electrophoresis, and kinetic parameter analysis. The leukocyte enzyme from healthy and mastitic cows displayed very similar characteristics, suggesting that the increase in activity during mastitis is most probably related to the enhanced expression of the normal alkaline phosphatase enzyme.

Alkaline Phosphatase↗

Effect of interferon-gamma on the production of tumor necrosis factor during acute Escherichia coli mastitis.

The effects of recombinant interferon-gamma on the production of tumor necrosis factor in 10 dairy cows with Escherichia coli mastitis were determined. Prophylactic administration of recombinant interferon-gamma prior to the experimental E. coli challenge was effective in modifying the production of endogenous tumor necrosis factor during acute stages of disease. Elevated tumor necrosis factor concentrations were especially evident in cows that developed severe clinical symptoms and eventually died from endotoxemia. These results indicate that both milk and sera tumor necrosis factor concentrations are associated closely with the manifestation of peracute signs of coliform mastitis and are important factors contributing to morbidity and mortality of endotoxic shock. Pretreatment of cows with recombinant interferon-gamma possibly may down-regulate the generation of this potent endogenous inflammatory mediator within infected quarters. Controlling severe inflammation with recombinant interferon-gamma may prevent the tremendous loss in milk production and death that often accompany acute coliform mastitis during the periparturient period.

Animals↗

Genetic and environmental relationships among somatic cell count, bacterial infection, and clinical mastitis.

Incidence of bacterial infection in 9784 lactations of 7763 cows in 31 herds, SCC in 32,448 lactations of 19,764 cows from 54 herds, and incidence of first parity mastitis recorded in the first lactations of 148,143 cows in 828 herds were analyzed. Bacterial infection was analyzed dichotomously by both threshold and linear models. The effects of parity, season, stage of lactation, and parity by stage of lactation interaction on SCC were estimated. Heritability of mean lactation log SCC--corrected for the effects of parity, season, and stage of lactation--varied from .13 to .27 for all parities in different data sets. Heritability of bacterial infection was .04 for the threshold model and .02 for the linear models. Heritability of field-recorded mastitis was .01. The genetic correlation between bacterial infection and SCC was near unity, but the genetic correlation between SCC and mastitis was .3. Selection for lowered SCC should reduce incidence of bacterial infection by 2% per unit of selection intensity.

Animals↗

Use of modified Rambach agar to differentiate Streptococcus uberis from other mastitis streptococci.

The medium of Rambach was modified to permit differentiation of mastitis streptococci. A total of 377 streptococci isolated from bovine IMI was used in the study. Of the 159 strains identified as Streptococcus uberis, 151 strains (94.9%) were beta-galactosidase-positive and yielded blue colonies on modified Rambach agar. In comparison, Streptococcus agalactiae, Streptococcus dysgalactiae, Enterococcus saccharolyticus, or Enterococcus faecalis strains were negative for propylene glycol utilization (red colonies) or beta-galactosidase production; all strains yielded colorless colonies on modified Rambach agar. However, 5 of 35 (14.3%) Streptococcus equinus strains were also positive for beta-galactosidase. Results indicate that modified Rambach agar is a convenient medium for the differentiation of the Strep. uberis from the other mastitis streptococci. Furthermore, modified Rambach agar could be easily incorporated as a screening medium for Strep. uberis in mastitis bacteriology laboratories.

Agar↗

Evaluation of a prototype on-line electrical conductivity system for detection of subclinical mastitis.

A prototype on-line system for measurement of electrical conductivity of quarter milk was evaluated for accuracy in detection of subclinical mastitis compared with that of bacteriological culture and SCC of sampled quarters. Because of the low quarter prevalence of mastitis, quarters were sampled conditionally from the signals of the on-line system. All signaled quarters and a random selection of the nonsignaled quarters were sampled. To calculate sensitivity and specificity, the total number of non-signaled quarters was extrapolated. The system identified correctly 18 out of 23 subclinical quarters and 521 out of 555 healthy quarters. Quarter prevalence was about 1%. Predictive value of a positive test (35%) and the predictive value of a negative test (99%) were calculated, as well as sensitivity (25%) and specificity (99%), after extrapolation of the total number of nonsignaled quarters. Because of repeated measurements, sensitivity may be underestimated. When signaled quarters were defined by repeated signals within 14 d, predictive value positive increased to 48%. The prototype on-line system did not detect subclinical mastitis very accurately because of suboptimal test characteristics.

Animals↗

Effects of an Escherichia coli J5 vaccine on mild clinical coliform mastitis.

Efficacy of an Escherichia coli (O111:B4) J5 bacterin was tested in an experimental challenge trial. Nineteen cows were vaccinated with an E. coli J5 bacterin, and 10 cows were injected with a placebo containing adjuvant only. Vaccine and placebo were administered at drying off, 30 d after drying off, and within 48 h after calving. Cows were challenged approximately 30 d after calving by intramammary infusion with a smooth heterologous strain of E. coli previously shown to cause mild clinical mastitis. Vaccination with the J5 bacterin reduced duration of IMI and local signs of clinical mastitis. Concentrations of BSA in milk 24 h after challenge were greater in control cows than in cows vaccinated with J5. The SCC at 7 d postchallenge were greater for cows vaccinated with the placebo than for cows vaccinated with J5. Bacterial counts were lower for cows vaccinated with the placebo than for cows vaccinated with J5 at 3, 6, and 9 h postchallenge. In contrast, cows vaccinated with J5 had lower bacterial counts at 2, 3, and 4 d postchallenge than did cows vaccinated with placebo. Systemic signs of clinical mastitis were relatively mild and similar between treatment groups. Rectal temperature, DMI, and milk production did not differ between control and cows vaccinated with J5 following challenge.

Administration, Topical↗

Detection of subclinical mastitis from on-line milking parlor data.

A model, based on automatically collected data, was developed for detection of subclinical mastitis. The logistic regression model was based on the following variables: milk electrical conductivity, milk production, parity, and DIM. Subclinical mastitis was defined as a minimal period of 1 wk in which the SCC was > 500 x 10(3) cells/ml. In contrast, periods were defined as healthy if the SCC was < 200 x 10(3) cells/ml. The resulting model had a sensitivity of 55% and specificity of 90% for individual milkings. For periods of 14 milkings, sensitivity was 54% and specificity 92% when the threshold for that period was > 6 electrical conductivity signals for high SCC. Based on these test characteristics, the model could be used as an initial screening tool in a herd with a high incidence of subclinical mastitis. Cows with a signal would have a higher probability of being diseased than the total population. In such herds, separation of milk from the signaled cows might be a possible management strategy to reduce the SCC in the bulk milk tank.

Animals↗

Mastitis in dairy heifers: initial studies on prevalence and control.

Initial studies to determine the prevalence of mastitis in heifers of breeding age and in pregnant dairy heifers demonstrated that IMI were present in 97% of heifers and 75% of quarters. The most common isolates were Staphylococcus aureus, Staphylococcus hyicus, and Staphylococcus chromogenes; SCC ranged from 12.4 to 17.3 x 10(6)/ml. Approximately 29% of heifers and 15% of quarters exhibited clinical mastitis at breeding age, as evidenced by clots or flakes in mammary secretions. Histologic examination of mammary tissues demonstrated significant reductions in alveolar epithelial and luminal areas and increases in connective tissue stroma and leukocytosis, illustrating limited development and marked inflammation of infected tissues. A one-time infusion of antibiotic for nonlactating cows into infected quarters > or = 45 d prepartum reduced incidence of IMI by 59% at calving compared with the pretreatment level; the cure rate for Staph. aureus IMI was > 90%. Prophylactic treatment of uninfected quarters > or = 45 d prepartum reduced new Streptococcus sp. IMI by 93%. The mean SCC was 50% lower at calving for treated heifers, and milk yield over the first 2 mo of lactation was 10% greater than that of untreated controls. Heifers from herds using fly control had a lower prevalence of IMI than herds without fly control. Prevalences of IMI and SCC in dairy heifers were higher than previously realized, but mastitis at calving was controlled by use of therapeutic products for nonlactating cows during pregnancy.

Animals↗

Mastitis of periparturient Holstein cattle: a phenotypic and genetic study.

Environmental and genetic factors affecting somatic cell scores, clinical mastitis, and IMI by minor and major pathogens were studied on 137 periparturient Holstein cows selected for milk production. Environmental effects were obtained by generalized least squares and logistic regression. Genetic parameters were from BLUP and threshold animal models. Lactation number affected the number of quarters with clinical mastitis and the number of quarters infected with minor pathogens. The DIM affected somatic cell score and number of quarters infected with major pathogens. Heritabilities for all mastitis indicators averaged 10%, but differences occurred among the indicators. Correlations between breeding values of the number of quarters infected with minor pathogens and the number infected with major pathogens were antagonistic and statistically significant.

Animals↗

Efficacy of a barrier teat dip containing .55% chlorhexidine for prevention of bovine mastitis.

A natural exposure trial was conducted for 12 mo in a commercial herd of 125 lactating cows to compare the efficacy of an experimental barrier teat dip containing .55% chlorhexidine gluconate with the efficacy of a 1% iodophor for preventing new IMI and clinical mastitis. Teats of half of the cows were dipped in the experimental barrier product, and teats of the remaining half of the herd were dipped in the 1% iodophor product. Quarters dipped with the experimental barrier product had fewer new IMI caused by Escherichia coli, coagulase-negative staphylococci, or Gram-positive bacilli than did quarters dipped in the 1% iodophor. Incidence of new IMI caused by Serratia spp. and Pseudomonas spp. was greater for quarters dipped in the experimental barrier product than for quarters dipped in the 1% iodophor. Efficacy of the two teat dips against new IMI caused by Staphylococcus aureus, environmental streptococci, and Klebsiella spp. did not differ. Incidence of bacteriologically negative clinical cases of mastitis was greater in quarters dipped in the 1% iodophor than in quarters dipped in the experimental barrier product. Incidence of clinical mastitis cases caused by Staph. aureus, environmental streptococci, E. coli, Klebsiella spp., Serratia spp., and Pseudomonas spp. did not differ between treatment groups.

Animals↗

Detection of clinical mastitis by changes in electrical conductivity of foremilk before visible changes in milk.

Mastitis was induced by the direct infusion of Staphylococcus aureus or Streptococcus uberis into the mammary gland of lactating cows. Changes in electrical conductivity of foremilk indicated the establishment of bacteria, increased SCC, increased clotting of milk, and, hence, disease, in advance of visible changes in the milk that could be diagnosed by a herdsperson. Clinical mastitis was detectable by changes in electrical conductivity of foremilk, 90% of cases were detectable when clots first appeared in foremilk, and 55% of cases were detectable up to 2 milkings prior to the appearance of clots. All subclinical infections from Staph. aureus were detected, but subclinical infections from Strep. uberis were not detected. The results suggested that clinical mastitis caused by these two major pathogens could be detected earlier by measuring changes in electrical conductivity of milk than by waiting for a herdsperson to detect visible changes in milk. Earlier detection would permit earlier treatment. However, the handheld sensor used in this experiment is impractical for commercial application, and reliable automated sensors and decision-making algorithms are required.

Animals↗

Efficacy of cefquinome for treatment of cows with mastitis experimentally induced using Escherichia coli.

The efficacy of intramuscularly and intramammarily administered cefquinome was evaluated in experimental Escherichia coli mastitis in dairy cows. Forty-seven multiparous, Israeli Holstein cows in early lactation that produced at least 25 L/d of milk were used, and 400 to 750 cfu of E. coli were infused into two healthy quarters of each cow. Cows were randomly assigned to one of the following treatment groups: 1) 75 mg of cefquinome administered intramammarily three times at 12-h intervals, 2) 75 mg of cefquinome administered intramammarily three times at 12-h intervals and 1 mg/kg of cefquinome administered intramuscularly two times at a 24-h interval, 3) 1 mg/kg of cefquinome administered intramuscularly two times at a 24-h interval, and 4) 75 mg of ampicillin and 200 mg of cloxacillin administered intramammarily three times at 12-h intervals. All cows developed typical signs of acute clinical mastitis by 12 to 16 h postinoculation. Parenteral cefquinome therapy, with or without intramammary cefquinome (groups 2 and 3), significantly improved clinical recovery and return to milk production. The bacteriological cure rates were considerably and significantly higher for cows in the groups treated with cefquinome than for cows in the group treated with ampicillin and cloxacillin. This study supported the efficacy of cefquinome in the treatment of clinical coliform mastitis in dairy cows.

Animals↗

Bacteria associated with clinical mastitis in dairy heifers.

A 1-yr field investigation of clinical mastitis in heifers was carried out in 24 veterinary districts in Norway. Quarter lacteal secretions from cases that occurred prepartum or within 14 d postpartum were examined bacteriologically. The study included 1040 heifers with clinical mastitis, and the total number of quarters that were clinically affected was 1361. The organisms that were most frequently isolated from samples from these quarters were Staphylococcus aureus (44.3%), Streptococcus dysgalactiae (18.2%), Staph. aureus together with Strep. dysgalactiae (1.2%), coagulase-negative staphylococci (12.8%), Arcanobacterium pyogenes (3.5%), A. pyogenes together with Strep. dysgalactiae (0.5%) or Staph. aureus (0.4%), and Escherichia coli (6.4%). Of the coagulase-negative staphylococci, Staphylococcus simulans (53.7%), Staphylococcus hyicus (14.8%), and Staphylococcus chromogenes (14.8%) were the most prevalent species. Except for a higher relative percentage of A. pyogenes in cases that occurred before parturition (8.2%) than in cases that occurred after parturition (2.7%), no significant differences were observed in the distribution of the various organisms among prepartum and postpartum cases. Regional variations were observed in the distribution of organisms. The proportions of Staph. aureus and A. pyogenes were highest, and the proportion of coagulase-negative staphylococci was lowest, in late autumn and early winter. The proportion of E. coli was highest in summer. In heifers in which mastitis was associated with increased rectal temperature or other systemic signs, the proportion of clinically affected quarters that were infected with Staph. aureus was larger than that in heifers without systemic reaction.

Actinomyces↗

Management style and its association with bulk milk somatic cell count and incidence rate of clinical mastitis.

Management style and its association with bulk milk somatic cell count (SCC) and the incidence rate of clinical mastitis were studied in 300 Dutch dairy herds. Cluster analysis was used to identify groups of farmers who had similar management styles for the prevention of mastitis. Two groups of farmers could be differentiated. The management style of the first group of farmers was described as clean and accurate; the management style of the second group of farmers was described as quick and dirty. The relationship between clusters and the bulk milk SCC category was high. The relationship between clusters and incidence rate of clinical mastitis was weak. Compared with herds with a high (250,000 to 400,000 cells/ml) bulk milk SCC, herds with a low bulk milk SCC (< or = 150,000 cells/ml) were managed by farmers who were younger, had children with a higher education, and were more eager to invest. Farmers of herds with a low bulk milk SCC kept better records and were more familiar with each cow in their herds. The most striking difference between farmers of herds with low and high bulk milk SCC was that the first group worked precisely rather than fast; the latter group of farmers worked quickly rather than precisely. As a result, the farms with herds that had a low bulk milk SCC had better hygienic conditions than those farms with herds that had a high bulk milk SCC. We also discuss the implications for producer education with regard to udder health.

Age Factors↗

Changes in milk protein fraction as affected by subclinical mastitis.

From cows that had both healthy quarters and quarters with subclinical mastitis [somatic cell count (SCC) 84,000 vs. 293,000/ml in bucket milk], foremilk, bucket milk, and stripping and residual milks were collected. Young milk was obtained 1.5 h later following a repeated oxytocin injection. Compared with milk from healthy quarters, milk from quarters with subclinical mastitis showed elevated SCC, plasminogen, and protein and had increased activity of n-Acetyl-beta-D-glucosaminidase (NAGase) and plasmin, as well as elevated portions of whey proteins and gamma-casein in the total protein. The SCC and the other mentioned parameters were also higher in the foremilk and the stripping and residual milks compared with bucket milk, independent of the udder health status; however, decreased values were found for total protein. Young milk showed an increase of SCC and n-Acetyl-beta-D-glucosaminidase activity compared with bucket milk. Because of lower levels of total plasmin and gamma-casein, we concluded that this young milk was newly synthesized milk containing some casein degradation products and that proteolysis of casein continued in the udder until the next milking. The n-Acetyl-beta-D-glucosaminidase activity was shown to be a better indicator for subclinical mastitis and correlated better with protein degradation than did SCC.

Acetylglucosaminidase↗

The prevalence of subclinical mastitis in dairy goats in Kenya.

California mastitis test (CMT), direct leukocytes counts and bacteriological examination were performed on 630 milk samples from apparently healthy mammary glands of dairy goats comprising a mixed population of German Alpine, Toggenberg, Saanen and Galla crosses to find the prevalence of subclinical mastitis. The prevalence of subclinical mastitis was 9.8% according to CMT, 9.7% according to direct leukocyte counts and 28.7% by bacterial isolation during a 3-month period. The proportion of the bacteriologically positive milk samples was significantly (P <0.01) higher than that positive for CMT and direct leukocyte counts. There was a significant (P < 0.01) correlation between CMT and direct leukocyte counts. There was no significant direct relationship between bacterial isolation and CMT Bacterial organisms were isolated in 22.5% of the 568 CMT-negative milk samples. The results suggest that bacterial organisms isolated from the CMT-negative milksamples were either latent infections or did not stimulate any significant increase in somatic cell counts that could be detected by either the CMT or direct leukocyte counts. The observations of this study indicate that the mere presence of bacteria in goat's milk does not mean that the udder is infected and so does not warrant antibiotic therapy.

Animals↗